IgA Nephropathy (IgAN)

Nephrology
3
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

BioCity Biopharma
BioCity BiopharmaChina - Wuxi
1 program
1
SC0062 strength 10mgPhase 31 trial
Active Trials
NCT06819826RecruitingEst. Dec 2028
Vera Therapeutics
Vera TherapeuticsBRISBANE, CA
2 programs
2
AtaciceptPhase 21 trial
Atacicept 150 mgPhase 21 trial
Active Trials
NCT07020923Recruiting90Est. Sep 2027
NCT06674577Enrolling By Invitation476Est. May 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
BioCity BiopharmaSC0062 strength 10mg
Vera TherapeuticsAtacicept
Vera TherapeuticsAtacicept 150 mg

Clinical Trials (3)

Total enrollment: 566 patients across 3 trials

NCT06819826BioCity BiopharmaSC0062 strength 10mg

A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

Start: Feb 2025Est. completion: Dec 2028
Phase 3Recruiting
NCT07020923Vera TherapeuticsAtacicept

Monthly Dosing of Atacicept in IgAN

Start: May 2025Est. completion: Sep 202790 patients
Phase 2Recruiting
NCT06674577Vera TherapeuticsAtacicept 150 mg

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Start: Dec 2024Est. completion: May 2028476 patients
Phase 2Enrolling By Invitation

Related Jobs in Nephrology

Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery

AstraZeneca
Sweden - Gothenburg
1w ago

Associate Director – Nephrology Market Access Strategy

Biogen
Cambridge, MA
1w ago
$164K - $226K/yr

Director, Strategy & Operations-Nephrology Franchise

Biogen
Cambridge, MA
1w ago
$195K - $269K/yr

Medical Science Liaison, CardioRenal - Portland, OR

AstraZeneca
Portland - OR, US
1w ago

Vice President, Head of Renal Sales

Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr

Specialty Account Manager, Nephrology- South Houston, Texas

Amgen
Texas - Houston, US
1w ago
$155K - $184K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 566 patients
3 companies competing in this space

Related Indications

Chronic Kidney Disease(86)Renal Impairment(67)End Stage Renal Disease(56)Kidney Transplantation(49)Renal Insufficiency(27)Chronic Kidney Diseases(25)Kidney Transplant(19)Diabetic Nephropathies(18)Kidney Diseases(17)Kidney Transplant Rejection(16)